Cargando…
High-dose vitamin D substitution in patients with COVID-19: study protocol for a randomized, double-blind, placebo-controlled, multi-center study—VitCov Trial
BACKGROUND: The coronavirus disease 19 (COVID-19) pandemic has caused millions of deaths, and new treatments are urgently needed. Factors associated with a worse COVID-19 prognosis include old age (> 65 years), ethnicity, male sex, obesity, and people with comorbidities. Furthermore, vitamin D de...
Autores principales: | Jaun, Fabienne, Boesing, Maria, Lüthi-Corridori, Giorgia, Abig, Kristin, Makhdoomi, Anja, Bloch, Nando, Lins, Christina, Raess, Andrea, Grillmayr, Victoria, Haas, Philippe, Schuetz, Philipp, Gabutti, Luca, Muser, Jürgen, Leuppi-Taegtmeyer, Anne B., Giezendanner, Stéphanie, Brändle, Michael, Leuppi, Jörg D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814790/ https://www.ncbi.nlm.nih.gov/pubmed/35120577 http://dx.doi.org/10.1186/s13063-022-06016-2 |
Ejemplares similares
-
Effect of Single High Dose Vitamin D Substitution in Hospitalized COVID-19 Patients with Vitamin D Deficiency on Length of Hospital Stay
por: Jaun, Fabienne, et al.
Publicado: (2023) -
Is Serum 25-Hydroxyvitamin D Level Associated with Severity of COVID-19? A Retrospective Study
por: Mbata, Munachimso Kizito, et al.
Publicado: (2023) -
Predictors of Length of Stay, Rehospitalization and Mortality in Community-Acquired Pneumonia Patients: A Retrospective Cohort Study
por: Lüthi-Corridori, Giorgia, et al.
Publicado: (2023) -
Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trial
por: Boesing, Maria, et al.
Publicado: (2022) -
Risk factors for hospital outcomes in pulmonary embolism: A retrospective cohort study
por: Lüthi-Corridori, Giorgia, et al.
Publicado: (2023)